MADISON, Wis.--(BUSINESS WIRE)--HealthMyne, an imaging informatics company, was selected as the “Most Promising Company”, the top award at the Personalized Medicine World Conference in Silicon Valley. The competition involved two rounds of presentations and selection by a panel of judges, including venture capitalists from Mérieux Développement, Five Prime Ventures, Data Collective, and Faridan Ventures.
“While our FDA cleared software provides workflow efficiencies for radiologists, we came to PMWC in Silicon Valley to highlight the role that our imaging informatics can play in precision medicine,” said Mark Gehring, Chief Strategy Officer at HealthMyne. “Imaging plays a significant role in cancer management, from diagnosis to treatment planning and monitoring. Providing image-based quantitative measurements will not only expand that role but also allow for advanced decision support for clinicians.”
“Having a company that is developing imaging solutions for precision medicine receive the highest award shows we are achieving our goal to bring diverse solutions to the forefront,” said Tal Behar, co-founder and President of PMWC.
HealthMyne is an imaging informatics company dedicated to transforming patient care by enabling image data mining within the clinical workflow. Built on an FDA-cleared diagnostic platform, HealthMyne tools will increase radiologist efficiency by automating both data capture and structured reports. HealthMyne software combines imaging and electronic health record data to provide stakeholders with integrated patient progression timelines as well as analytics for comparing individual patients to specific populations. Academic and industrial researchers can also use HealthMyne analytic tools to explore quantitative imaging biomarkers, including radiomic signature development, as well as supporting improved clinical trials of innovative therapies. For more information, please visit http://www.healthmyne.com/.
The Personalized Medicine World Conference (PMWC) is an independent and established conference that attracts recognized authorities and experts across healthcare and biotechnology sectors. The Conference showcases practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional collaboration to further adoption of personalized medicine in the clinic. The event co-hosts include Stanford Health Care, Oracle Health Sciences, and University of California San Francisco (UCSF). For more information: http://2016sv.pmwcintl.com/